Premium
Oncolytics Biotech Inc (ONCY)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as qui... Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The company's product pipeline includes Bavencio, Keytruda, Retifanlimab, and Tecentriq. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0658 | -8.77333333333 | 0.75 | 0.75 | 0.681 | 229788 | 0.70794431 | CS |
| 4 | -0.0504 | -6.86087666757 | 0.7346 | 0.84 | 0.67 | 435484 | 0.75255387 | CS |
| 12 | -0.1958 | -22.25 | 0.88 | 1.06 | 0.67 | 1265087 | 0.82593934 | CS |
| 26 | -0.2858 | -29.4639175258 | 0.97 | 1.53 | 0.67 | 800627 | 0.92621833 | CS |
| 52 | -0.3758 | -35.4528301887 | 1.06 | 1.53 | 0.67 | 516339 | 0.95544511 | CS |
| 156 | -0.9558 | -58.2804878049 | 1.64 | 3.3942 | 0.67 | 413105 | 1.53100199 | CS |
| 260 | -1.3558 | -66.4607843137 | 2.04 | 4.83 | 0.67 | 560293 | 2.16696272 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
